Drugdiscovery >> Clinical Trials >> News
3458
Views
New Clinical trial for curin B-cell Cancer - drugdiscovery.com
New Clinical trial for curin B-cell Cancer - drugdiscovery.com


Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its therapeutic drug candidate, SNS01-T, targeting B-cell cancers.
Read More >>


Tags: B-cell, research, cancer - October 26, 2013
Related Articles
17764
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

21003
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

8154
Views
Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung Promising results of Reolysin in Phase 2 clinical trial in patients with squamous cell carcinoma of the lung
Oncolytics Biotech’s drug Reolysin, used in combination with carboplatin and paclitaxel, has shown high tumor shrinkage in patients with metastatic or recurrent squamous cell carcinoma of the lung Read More >>

Tags: Reolysin, clinical trial, squamous cell carcinoma of the lung, SCCLC, Oncolytics Biotech

3850
Views
CCL Clinical trial through the eyes of a patient CCL Clinical trial through the eyes of a patient
ABT-199 is a chronic lymphocytic leukemia (CLL) drug at Phase 1. Harley Hudson is taking part in the trial and hopes to get at least a long term solution for his illness. Read More >>

Tags: solution, illness, CLL, chronic lymphocytic leukemia, clinical trial, cancer

3316
Views
The biggest heart-trial takes place The biggest heart-trial takes place
The biggest heart-related clinical trial is going to take place in London. Stem cell technology is going to be tested on patient, some of whom has already gone through heart-attack. Read More >>

Tags: heart attack, stem cell, clinical trial

4053
Views
Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis Pacritinib to be tested in a late-stage trial as a treatment for myelofibrosis
Cell Therapeutics announced a late-stage trial of pacritinib as a treatment for a blood disorder called myelofibrosis. Pacritinib will be compared to the best available treatment for myelofibrosis, Ja Read More >>

Tags: Pacritinib, Cell Therapeutics, myelofibrosis, clinical trial, treatment

8137
Views
AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer
AstraZeneca has initiated the enrollment of patients for a Phase III (SOLO) clinical program of its drug olaparib. The drug will be tested as a maintenance monotherapy in patients with BRCA mutated ov Read More >>

Tags: ovarian cancer, clinical trial, olaparib, AstraZeneca, SOLO, BRCA mutation, PARP inhibitor

6400
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

7146
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

3428
Views
New clinical trial in ovarian cancer New clinical trial in ovarian cancer
Adaptimmune has opened a Phase I/IIa clinical trial at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif. The patients will be treated with their own T ce Read More >>

Tags: ovarian cancer, T cells, cancer immunotherapy, TCR enhancement technology, CT antigens

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013